Biomedical Japan Inc. is a strategic consulting and investment advisory firm serving the global medical devices, diagnostics, pharmaceutical and biotechnology industries with particular focus on opportunities in Asia-Pacific.
The Asia market is huge and growing. With a 3.5 billion population, some 60% of the world total, Asia Pacific’s healthcare markets offer significant scope for growth compared with the established markets of the U.S. and Europe.
The Asian pharmaceutical market was worth some US$159 billion in 2008. Medical technology in Asia-Pacific accounted for approximately US$81 billion of a global market valued at US$315 billion in 2008.
There are many ways for companies to tap into this vast business potential but key to success is to understand the nature of the market. Asia is not a coherent whole. Each country has its distinct way of doing business in terms of regulations, practices, sales channels and approach to decision-making and relationship building. What succeeds in one country may fail in another. Local knowledge is essential.
We are strategically located in Tokyo, with offices in Singapore, Malaysia, Mumbai, Shanghai, Sydney and additional partners and associates in other Asian nations and Europe and North America. With over 100 years’ combined experience from the biomedical sciences industry in Asia-Pacific, Biomedical Strategy Consultants is ideally positioned to assist Asian, European and North America based healthcare companies to fully exploit the opportunities in the region.